Quotient Clinical, the Translational Pharmaceutics company, will be highlighting the benefits of its unique, integrated approach to formulation development, real-time adaptive manufacturing and clinical testing on booth 1662 at this year’s American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition.
Held in Orlando, Florida, from the 25–29 of October, this meeting provides attendees with an opportunity to see some of the latest developments in the pharmaceutical sector. Quotient Clinical will be presenting six posters describing projects that have benefited from the reduced costs and shorter development timelines offered by the company’s pioneering Translational Pharmaceutics.
Quotient will also host the fourth Annual RapidFACT User Group Meeting in Orlando on 27 October. Delegates at this event will have the chance to learn more about how this innovative approach is helping pharmaceutical development teams to accelerate drug production optimization.
RapidFACT has already been used in hundreds of early development and lifecycle management programmes, and a number of customers – including Upsher-Smith Laboratories and Stealth BioTherapeutics – will present case studies illustrating how it has enhanced their development projects. This will be followed by a discussion on emerging applications and a complimentary lunch, providing an informal opportunity to network with leading industry figures.
To register for the RapidFACT User Group Meeting, visit booth 1662 or go to www.quotientclinical.com/usergroup2015.